Loading company…
NanoPass develops MicronJet™ intradermal delivery devices for vaccines and drugs.
NanoPass Technologies Ltd develops intradermal delivery systems, including its MicronJet™ platform for delivering vaccines and drugs through the skin. Its customers include healthcare providers and pharmaceutical companies. Founded in 2000, the company is based in Israel. It has raised USD 4.00 mn, with its latest round led by AWZ Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in